Aspen Neuroscience Gets $70 Million Series A Funding Round
Tuesday, April 14, 2020
Photo courtesy of Aspen Neuroscience. Laboratory workers at Aspen Neuroscience work on Parkinson’s disease treatments.
Aspen Neuroscience, a private biotech company developing the first autologous neuron replacement therapy to treat Parkinson’s disease, announced the close of its Series A funding round of $70 million...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know